Protective Impacts of Quercetin and Echinochrome on Female Fertility and Pregnancy Outcomes in Polycystic Ovary Syndrome in Rats
article
OA: bronze
CC0
⤵ 1 in-corpus citation
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is a universal reproductive, endocrine, and metabolic disorder. It affects 9.2% of women worldwide. Echinochrome (Ech) is the most common dark red pigment of sea urchin shells and possesses high antioxidant and hypoglycemic properties. Quercetin (Quer) is a flavonol widely distributed in plants with high antioxidant properties. Therefore, Ech and Quer as a combined protective therapy were investigated against letrozole and high-fat diet-induced PCOS model in rats. METHODS: Sixty female rats were divided randomly into five groups: Control: received 2% DMSO with a normal diet, PCOS: received letrozole with HFD, Ech: received letrozole and Ech with HFD, Quer: received letrozole and Quer with HFD, Ech + Quer: received letrozole, Ech, and Quer together daily orally for 4 weeks. Half of the rats in each group were sacrificed, and the remaining rats were examined for their ability to mate and fertility. RESULTS: Ech and Quer treatment restored normal levels of lipid and hormonal profiles, oxidative status, kidney and liver functions with a marked amelioration in ovarian, uterine histopathology, and a good evidence in pregnancy analysis. CONCLUSION: Ech and Quer were found to have a potent protective effect against PCOS, minimal side effects, and improved progeny outcomes in rats.
Full text
26,152 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Background
Polycystic ovary syndrome (PCOS) is a universal reproductive, endocrine, and metabolic disorder. It affects 9.2% of women worldwide. Echinochrome (Ech) is the most common dark red pigment of sea urchin shells and possesses high antioxidant and hypoglycemic properties. Quercetin (Quer) is a flavonol widely distributed in plants with high antioxidant properties. Therefore, Ech and Quer as a combined protective therapy were investigated against letrozole and high-fat diet-induced PCOS model in rats.
Methods
Sixty female rats were divided randomly into five groups: Control: received 2% DMSO with a normal diet, PCOS: received letrozole with HFD, Ech: received letrozole and Ech with HFD, Quer: received letrozole and Quer with HFD, Ech + Quer: received letrozole, Ech, and Quer together daily orally for 4 weeks. Half of the rats in each group were sacrificed, and the remaining rats were examined for their ability to mate and fertility.
Results
Ech and Quer treatment restored normal levels of lipid and hormonal profiles, oxidative status, kidney and liver functions with a marked amelioration in ovarian, uterine histopathology, and a good evidence in pregnancy analysis.
Conclusion
Ech and Quer were found to have a potent protective effect against PCOS, minimal side effects, and improved progeny outcomes in rats.
Conflicts of Interest
The authors declare no conflicts of interest.
Data Availability Statement
Research data are not shared.
References
- Abdelaziz, M. H., M. H. El-Dakdoky, T. A. Ahmed, and A. S. Mohamed. 2023. “Biological Impacts of the Green Synthesized Silver Nanoparticles on the Pregnant Albino Rats and Their Fetuses.” Birth Defects Research 115, no. 4: 441–457.
- Abdelaziz, M. H., E. Y. Salah EL-Din, M. H. El-Dakdoky, and T. A. Ahmed. 2019. “The Impact of Mesenchymal Stem Cells on Doxorubicin-Induced Testicular Toxicity and Progeny Outcome of Male Prepubertal Rats.” Birth Defects Research 111, no. 13: 906–919.
- Abraham Gnanadass, S., Y. Divakar Prabhu, and A. J. Valsala Gopalakrishnan. 2021. “Association of Metabolic and Inflammatory Markers With Polycystic Ovarian Syndrome (PCOS): An Update.” Archives of Gynecology and Obstetrics 303: 631–643.
- Akpinar, D., T. Mercan, H. Demir, S. Ozdemir, C. Demir, and S. J. Kavak. 2023. “Protective Effects of Thymoquinone on Doxorubicin-Induced Lipid Peroxidation and Antioxidant Enzyme Levels in Rat Peripheral Tissues.” Pakistan Veterinary Journal 43, no. 4: 651–658.
- Alahmadi, A. A., B. A. Alahmadi, L. F. Wahman, and N. A. El-Shitany. 2021. “Chamomile Flower Extract Ameliorates Biochemical and Histological Kidney Dysfunction Associated With Polycystic Ovary Syndrome.” Saudi Journal of Biological Sciences 28, no. 11: 6158–6166.
- Albrecht, E. W., C. A. Stegeman, P. Heeringa, R. H. Henning, and H. J. van Goor. 2003. “Protective Role of Endothelial Nitric Oxide Synthase.” A Journal of the Pathological Society of Great Britain and Ireland 199, no. 1: 8–17.
- Al-Gubory, K. H., P. A. Fowler, and C. J. Garrel. 2010. “The Roles of Cellular Reactive Oxygen Species, Oxidative Stress and Antioxidants in Pregnancy Outcomes.” International Journal of Biochemistry & Cell Biology 42, no. 10: 1634–1650.
- Amanat, S., F. Ashkar, M. H. Eftekhari, et al. 2021. “The Effect of Genistein on Insulin Resistance, Inflammatory Factors, Lipid Profile, and Histopathologic Indices in Rats With Polycystic Ovary Syndrome.” Clinical and Experimental Reproductive Medicine 48, no. 3: 236.
- Arora, S., P. Kaur, R. Garg, M. Kaur, and S. Rani. 2022. “Assessment of Vitamin D and Calcium Levels in Women With Pcos: An Observational Study.” Asian Journal of Pharmaceutical and Clinical Research 15, no. 12: 88–91.
- Atanasov, A. G., S. B. Zotchev, V. M. Dirsch, and C. T. Supuran. 2021. “Natural Products in Drug Discovery: Advances and Opportunities.” Nature Reviews Drug Discovery 20, no. 3: 200–216.
- Awonuga, A. O., O. G. Camp, and H. M. Abu-Soud. 2023. “A Review of Nitric Oxide & Oxidative Stress in Typical Ovulatory Women and in the Pathogenesis of Ovulatory Dysfunction in PCOS.” Reproductive Biology and Endocrinology 21, no. 1: 111.
- Ayyadurai, T., A. K. Moola, P. K. Mohan, S. K. Thiruppathi, A. Shanmugam, and R. K. Bollipo Diana. 2022. “Ameliorative Effects of Guilandina bonduc L. Aqueous Seed Extract on Letrozole Induced Polycystic Ovary Syndrome in Female Wistar Albino Rats.” Advances in Traditional Medicine 22, no. 4: 885–903.
- Bahreiny, S. S., A. Ahangarpour, N. Saki, et al. 2024. “Association of Free Radical Product and Polycystic Ovary Syndrome: A Systematic Review & Meta-Analysis.” Reproductive Sciences 31, no. 6: 1486–1495.
- Begum, N., K. Manipriya, and B. J. Veeresh. 2022. “Role of High-Fat Diet on Letrozole-Induced Polycystic Ovarian Syndrome in Rats.” European Journal of Pharmacology 917: 174746.
- Bellver, J., J. A. Martínez-Conejero, E. Labarta, et al. 2011. “Endometrial Gene Expression in the Window of Implantation Is Altered in Obese Women Especially in Association With Polycystic Ovary Syndrome.” Fertility and Sterility 95, no. 7: 2335–2341.
- Bracho, G. S., M. V. Acosta, G. A. Altamirano, et al. 2024. “Uterine Histopathology and Steroid Metabolism in a Polycystic Ovary Syndrome Rat Model.” Molecular and Cellular Endocrinology 585: 112198.
- Braga, C. P., R. D. F. F. Baptista, F. B. Peixoto, A. C. Momentti, F. H. Fava, and A. A. H. Fernandes. 2012. “Effects of Quercetin Administration on the Pregnancy Outcome of Diabetic Rats.” Journal of Diabetes and Metabolism 3, no. 2: 1000180.
10.4172/2155-6156.1000180Google Scholar
- Cao, J. J., and B. R. Gregoire. 2016. “A High-Fat Diet Increases Body Weight and Circulating Estradiol Concentrations but Does Not Improve Bone Structural Properties in Ovariectomized Mice.” Nutrition Research 36, no. 4: 320–327.
- Carrillo-Martinez, E. J., F. Y. Flores-Hernández, A. M. Salazar-Montes, H. F. Nario-Chaidez, and L. D. Hernández-Ortega. 2024. “Quercetin, a Flavonoid With Great Pharmacological Capacity.” Molecules 29, no. 5: 1000.
- Chen, T., F. Jia, Y. Yu, et al. 2022. “Potential Role of Quercetin in Polycystic Ovary Syndrome and Its Complications: A Review.” Molecules 27, no. 14: 4476.
- Chen, T., X. Zhang, G. Zhu, et al. 2020. “Quercetin Inhibits TNF-α Induced HUVECs Apoptosis and Inflammation via Downregulating NF-kB & AP-1 Signaling Pathway In Vitro.” Medicine 99, no. 38: e22241.
- Deepika, D., and P. K. Maurya. 2022. “Health Benefits of Quercetin in Age-Related Diseases.” Molecules 27, no. 8: 2498.
- dehghani Firouzabadi, R., A. Aflatoonian, S. Modarresi, L. Sekhavat, and S. J. MohammadTaheri. 2012. “Therapeutic Effects of Calcium and Vitamin D Supplementation in Women With PCOS.” Complementary Therapies in Clinical Practice 18, no. 2: 85–88.
- Dolanbay, T., M. Makav, A. Vural, et al. 2024. “The Effect of Letrozole on Liver Function and Some Biochemical Parameters in Rats.” Journal of Advances in VetBio Science & Techniques 9, no. 1: 65–72.
10.31797/vetbio.1451147Google Scholar
- Dumesic, D. A., S. E. Oberfield, E. Stener-Victorin, J. C. Marshall, J. S. Laven, and R. S. Legro. 2015. “Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.” Endocrine Reviews 36, no. 5: 487–525.
- EL-Din, E. Y. S., A. S. Mohamed, N. A. Farag, and A. R. Tawfik. 2019. “Echinchrome Pigment Isolated From Sea Urchin Improves Female Rat's Fertility.” American Journal of Biomedical Science and Research 3: 144–147.
10.34297/AJBSR.2019.03.000651Google Scholar
- Fahmy, S. R., D. A. Sayed, A. M. Soliman, N. Y. Almortada, and W. E. Aal. 2019. “Protective Effect of Echinochrome Against Intrahepatic Cholestasis Induced by Alpha-Naphthylisothiocyanate in Rats.” Brazilian Journal of Biology 80, no. 1: 102–111.
10.1590/1519-6984.192697Google Scholar
- Farag, N. A., A. S. Mohamed, H. F. El Sayed, S. E. Din, Y. Eman, and A. R. Tawfik. 2022. “Echinochrome Pigment Improves Male Rats' Fertility.” Natural Products Journal 12, no. 3: 80–86.
- Feng, L., X.-F. Lin, Z.-H. Wan, D. Hu, and Y.-K. Du. 2015. “Efficacy of Metformin on Pregnancy Complications in Women With Polycystic Ovary Syndrome: A Meta-Analysis.” Gynecological Endocrinology 31, no. 11: 833–839.
- Furat Rencber, S., S. Kurnaz Ozbek, C. Eraldemır, et al. 2018. “Effect of Resveratrol & Metformin on Ovarian Reserve and Ultrastructure in PCOS: An Experimental Study.” Journal of Ovarian Research 11: 1–16.
- Gibori, G., and P. L. Keyes. 1978. “Role of Intraluteal Estrogen in the Regulation of the Rat Corpus Luteum During Pregnancy.” Endocrinology 102, no. 4: 1176–1182.
- Glendining, K. A., and R. E. Campbell. 2023. “Recent Advances in Emerging PCOS Therapies.” Current Opinion in Pharmacology 68: 102345.
- Goswami, S., S. Choudhuri, B. Bhattacharya, et al. 2021. “Chronic Inflammation in Polycystic Ovary Syndrome: A Case–Control Study Using Multiple Markers.” International Journal of Reproductive BioMedicine 19, no. 4: 313.
- He, R., C. Ma, L. Yu, et al. 2024. “Research on the Self-Healing Ability of Polycystic Ovarian Syndrome (PCOS) in Mice Model & Its Impact on Offspring.”
- Horst, R., H. DeLuca, and N. J. Jorgensen. 1978. “The Effect of Age on Calcium Absorption and Accumulation of 1, 25-Hydroxyvitamin D3 in Intestinal Mucosa of Rats.” Metabolic Bone Disease & Related Research 1, no. 1: 29–33.
- Hu, M., Y. Zhang, X. Guo, et al. 2019. “Hyper&Rogenism and Insulin Resistance Induce Gravid Uterine Defects in Association With Mitochondrial Dysfunction and Aberrant Reactive Oxygen Species Production.” American Journal of Physiology. Endocrinology and Metabolism 316, no. 5: E794–E809.
- Huang, Y., and X. J. Zhang. 2021. “Luteolin Alleviates Polycystic Ovary Syndrome in Rats by Resolving Insulin Resistance and Oxidative Stress.” American Journal of Physiology. Endocrinology and Metabolism 320, no. 6: E1085–E1092.
- Iaccarino, G., M. Ciccarelli, D. Sorriento, et al. 2005. “Ischemic Neoangiogenesis Enhanced by β2-Adrenergic Receptor Overexpression: A Novel Role for the Endothelial Adrenergic System.” Circulation Research 97, no. 11: 1182–1189.
- Ibrahim, Y. F., M. Alorabi, W. Y. Abdelzaher, et al. 2022. “Diacerein Ameliorates Letrozole-Induced Polycystic Ovarian Syndrome in Rats.” Biomedicine & Pharmacotherapy 149: 112870.
- Jahan, S., A. Abid, S. Khalid, et al. 2018. “Therapeutic Potentials of Quercetin in Management of Polycystic Ovarian Syndrome Using Letrozole Induced Rat Model: A Histological and a Biochemical Study.” Journal of Ovarian Research 11: 1–10.
- Kamal, D. A. M., S. F. Ibrahim, A. Ugusman, and M. H. Mokhtar. 2022. “Kelulut Honey Ameliorates Oestrus Cycle, Hormonal Profiles, and Oxidative Stress in Letrozole-Induced Polycystic Ovary Syndrome Rats.” Antioxidants 11, no. 10: 1879.
- Khalid, S., M. Arshad, K. Raza, et al. 2023. “Assessment of Hepatoprotective, Nephroprotective Efficacy, and Antioxidative Potential of Moringa Oleifera Leaf Powder and Ethanolic Extract Against PCOS-Induced Female Albino Mice (Mus Musculus).” Food Science & Nutrition 11, no. 11: 7206–7217.
- Khorchani, M. J., F. Zal, and A. Neisy. 2020. “The Phytoestrogen, Quercetin, in Serum, Uterus and Ovary as a Potential Treatment for Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome in the Rat.” Reproduction, Fertility and Development 32, no. 3: 313–321.
- Kim, H. K., E. A. Vasileva, N. P. Mishchenko, S. A. Fedoreyev, and J. J. Han. 2021. “Multifaceted Clinical Effects of Echinochrome.” Marine Drugs 19, no. 8: 412.
- Kondo, H., T. Maruo, and M. J. Mochizuki. 1995. “Immunohistochemical Evidence for the Presence of Tumor Necrosis Factor-α in the Infant and Adult Human Ovary.” Endocrine Journal 42, no. 6: 771–780.
- Kumar, A., K. Sundaram, J. Mu, et al. 2021. “High-Fat Diet-Induced Upregulation of Exosomal Phosphatidylcholine Contributes to Insulin Resistance.” Nature Communications 12, no. 1: 213.
- Li, T., T. Zhang, T. Cui, et al. 2020. “Involvement of Endogenous Testosterone in Hepatic Steatosis in Women With Polycystic Ovarian Syndrome.” Journal of Steroid Biochemistry and Molecular Biology 204: 105752.
- Liu, D., Y. Gan, Y. Zhang, et al. 2023. “Fetal Genome Predicted Birth Weight and Polycystic Ovary Syndrome in Later Life: A Mendelian r&Omization Study.” Frontiers in Endocrinology 14: 1140499.
- Liu, Y., Z. Yu, S. Zhao, et al. 2021. “Oxidative Stress Markers in the Follicular Fluid of Patients With Polycystic Ovary Syndrome Correlate With a Decrease in Embryo Quality.” Journal of Assisted Reproduction and Genetics 38: 471–477.
- loannou, Y. A., and F. W. Chen. 1996. “Quantitation of DNA Fragmentation in Apoptosis.” Nucleic Acids Research 24, no. 5: 992–993.
- Luo, X., X.-M. Yang, W.-Y. Cai, et al. 2020. “Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women With Polycystic Ovary Syndrome.” International Journal of Endocrinology 2020, no. 1: 7580218.
- Mahmoud, A. A., A. M. Elfiky, and F. S. Abo-Zeid. 2022. “The Anti-&Rogenic Effect of Quercetin on Hyper&Rogenism and Ovarian Dysfunction Induced in a Dehydroepi&Rosterone Rat Model of Polycystic Ovary Syndrome.” Steroids 177: 108936.
- Maliqueo, M., M. Sun, J. Johansson, et al. 2013. “Continuous Administration of a P450 Aromatase Inhibitor Induces Polycystic Ovary Syndrome With a Metabolic and Endocrine Phenotype in Female Rats at Adult Age.” Endocrinology 154, no. 1: 434–445.
- Marouf, B. H., D. O. Ismaeel, A. H. Hassan, and O. J. Ali. 2022. “Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities.” Journal of Inflammation Research 15: 5185–5199.
- Meng, J., C. Ohlsson, G. A. Laughlin, et al. 2010. “Associations of Estradiol and Testosterone With Serum Phosphorus in Older Men: The Osteoporotic Fractures in Men Study.” Kidney International 78, no. 4: 415–422.
- Mihanfar, A., M. Nouri, L. Roshangar, and M. H. Khadem-Ansari. 2021a. “Therapeutic Potential of Quercetin in an Animal Model of PCOS: Possible Involvement of AMPK/SIRT-1 Axis.” European Journal of Pharmacology 900: 174062.
- Mihanfar, A., M. Nouri, L. Roshangar, and M. H. Khadem-Ansari. 2021b. “Ameliorative Effects of Fisetin in Letrozole-Induced Rat Model of Polycystic Ovary Syndrome.” Journal of Steroid Biochemistry & Molecular Biology 213: 105954.
- Mirseyyed, S. F., S. Zavareh, M. Nasiri, and H. J. Hashemi-Moghaddam. 2024. “An Experimental Study on the Oxidative Status and Inflammatory Levels of a Rat Model of Polycystic Ovary Syndrome Induced by Letrozole & a New High-Fat Diet.” International Journal of Fertility and Sterility 18, no. 1: 45.
- Mohamed, A. S., A. M. Soliman, and M. A. Marie. 2016. “Mechanisms of Echinochrome Potency in Modulating Diabetic Complications in Liver.” Life Sciences 151: 41–49.
- Morgante, G., I. Darino, A. Spanò, et al. 2022. “PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment.” Journal of Clinical Medicine 11, no. 15: 4509.
- Moustafa, M. A., A. S. Mohamed, A. I. Dakrory, and M. H. Abdelaziz. 2025. “Lepidium sativum Extract Alleviates Reproductive and Developmental Toxicity in Polycystic Ovary Syndrome Induced by Letrozole and High-Fat Diet in Rats.” Reproductive Sciences 32: 1338–1361.
- Nickoloff, J. A., A. S. Jaiswal, N. Sharma, et al. 2023. “Cellular Responses to Widespread DNA Replication Stress.” International Journal of Molecular Sciences 24, no. 23: 16903.
- Notaro, A. L. G., and F. T. Neto. 2022. “The Use of Metformin in Women With Polycystic Ovary Syndrome: An Updated Review.” Journal of Assisted Reproduction and Genetics 39, no. 3: 573–579.
- Oishi, Y., K. Asakawa, Y. Ishiwata, et al. 2024. “Autophagy in the Corpus Luteum Correlates With Tissue Growth in Pregnant Rats.” Journal of Reproduction and Development 70, no. 5: 286–295.
- Olaniyi, K. S., and S. E. Areloegbe. 2023. “Acetate: A Therapeutic c&Idate Against Renal Disorder in a Rat Model of Polycystic Ovarian Syndrome.” Journal of Steroid Biochemistry Molecular Biology 225: 106179.
- Ożarowski, M., P. Ł. Mikołajczak, R. Kujawski, et al. 2018. “Pharmacological Effect of Quercetin in Hypertension and Its Potential Application in Pregnancy-Induced Hypertension: Review of In Vitro, In Vivo, and Clinical Studies.” Evidence-Based Complementary and Alternative Medicine 2018, no. 1: 7421489.
- Palomba, S., M. A. De Wilde, A. Falbo, M. P. Koster, G. B. La Sala, and B. C. Fauser. 2015. “Pregnancy Complications in Women With Polycystic Ovary Syndrome.” Human Reproduction Update 21, no. 5: 575–592.
- Panti, A. A., C. E. Shehu, Y. Saidu, et al. 2018. “Oxidative Stress and Outcome of Antioxidant Supplementation in Patients With Polycystic Ovarian Syndrome (PCOS).” International Journal of Reproduction, Contraception, Obstetrics and Gynecology 7, no. 5: 1667.
10.18203/2320-1770.ijrcog20181892Google Scholar
- Pawelczak, M., J. Rosenthal, S. Milla, Y.-H. Liu, and B. J. Shah. 2014. “Evaluation of the Pro-Inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents With Polycystic Ovary Syndrome.” Journal of Pediatric and Adolescent Gynecology 27, no. 6: 356–359.
- Pham, T. K., T. H. T. Nguyen, H. R. Yun, et al. 2023. “Echinochrome a Prevents Diabetic Nephropathy by Inhibiting the PKC-Iota Pathway & Enhancing Renal Mitochondrial Function in Db/Db Mice.” Marine Drugs 21, no. 4: 222.
- Piltonen, T. T. 2016. “Polycystic Ovary Syndrome: Endometrial Markers.” Best Practice & Research. Clinical Obstetrics & Gynaecology 37: 66–79.
- Pokorska-Niewiada, K., M. Zietek, M. Swiatkowska-Freund, and M. J. Szczuko. 2023. “How Important Are Elements in Polycystic Ovary Syndrome? Should They Be Supplemented? A Systematic Review.” Ginekologia Polska 95, no. 2: 143–151.
- Rajashekar, S., S. G. Ravindran, M. Kakarla, et al. 2022. “Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review.” Cureus 14, no. 5: e25340.
- Refat, M. S., R. Z. Hamza, A. M. A. Adam, et al. 2021. “Quercetin/Zinc Complex & Stem Cells: A New Drug Therapy to Ameliorate Glycometabolic Control & Pulmonary Dysfunction in Diabetes Mellitus: Structural Characterization and Genetic Studies.” PLoS One 16, no. 3: e0246265.
- Roy, A., A. Khan, I. Ahmad, et al. 2022. “Flavonoids a Bioactive Compound From Medicinal Plants and Its Therapeutic Applications.” BioMed Research International 2022, no. 1: 5445291.
- Rudnicka, E., A. M. Duszewska, M. Kucharski, P. Tyczyński, and R. J. R. Smolarczyk. 2022. “Oxidative Stress and Reproductive Function: Oxidative Stress in Polycystic Ovary Syndrome.” Reproduction 164, no. 6: F145–F154.
- Saadia, Z. J. 2020. “Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS)-Obese vs. Non-Obese Women.” Medical Archives 74, no. 4: 289.
- Sadek, S. A., S. S. Hassanein, A. S. Mohamed, A. M. Soliman, and S. R. Fahmy. 2022. “Echinochrome Pigment Extracted From Sea Urchin Suppress the Bacterial Activity, Inflammation, Nociception, & Oxidative Stress Resulted in the Inhibition of Renal Injury in Septic Rats.” Journal of Food Biochemistry 46, no. 3: e13729.
- Salari, N., A. Nankali, A. Ghanbari, et al. 2024. “Global Prevalence of Polycystic Ovary Syndrome in Women Worldwide: A Comprehensive Systematic Review and Meta-Analysis.” Archives of Gynecology and Obstetrics 310: 1303–1314.
- Sazonova, E., M. Kuznetsova, E. Vasileva, N. Mishchenko, N. Tsimbalist, and О. J. Lebed'ko. 2020. “Cytoprotective Effect of Echinochrome A in Primary Culture of Pulmonary Fibroblasts From Albino Rats Under Conditions of Oxidative Stress.” Bulletin of Experimental Biology and Medicine 169: 582–585.
- Sharma, J. K., M. E. Turner, A. S. Paynter, et al. 2024. “Serum Total Testosterone Is Associated With Phosphate and Calcium Excretion in Response to Oral Phosphate Loading in Healthy Middle-Aged Males.” Andrology 12: 1668–1674.
- Soliman, A., A. Mohamed, and M. J. Marie. 2016a. “Effect of Echinochrome on Body Weight, Musculoskeletal System and Lipid Profile of Male Diabetic Rats.” Endocrinol Diabetes 3, no. 2: 1045.
- Soliman, A., A. Mohamed, and M. J. Marie. 2016b. “Comparative Study Between the Hypoglycemic and Antioxidant Effects of Echinochrome on Type 1 and Type 2 Diabetes Mellitus.” Biological Research 4: 2322.
- Song, X., Y. Wang, and L. J. Gao. 2020. “Mechanism of Antioxidant Properties of Quercetin and Quercetin-DNA Complex.” Journal of Molecular Modeling 26: 1–8.
- Tsikas, D. J. 2017. “Assessment of Lipid Peroxidation by Measuring Malondialdehyde (MDA) & Relatives in Biological Samples: Analytical and Biological Challenges.” Analytical Biochemistry 524: 13–30.
- Vaez, S., K. Parivr, F. Amidi, N. H. Rudbari, A. Moini, and N. J. Amini. 2023. “Quercetin and Polycystic Ovary Syndrome; Inflammation, Hormonal Parameters and Pregnancy Outcome: A Randomized Clinical Trial.” American Journal of Reproductive Immunology 89, no. 3: e13644.
- Vassalli, P. J. 1992. “The Pathophysiology of Tumor Necrosis Factors.” Annual Review of Immunology 10, no. 1: 411–452.
- Wu, X.-K., S.-K. Zhang, H. He, et al. 2022. “Associations of Serum Phosphorus Concentrations With Insulin Resistance and Hyper & Rogenemia in Normal Weight Women With Polycystic Ovary Syndrome.”
- Xiang, Y., H. Wang, H. Ding, et al. 2023. “Hyper&Rogenism Drives Ovarian Inflammation and Pyroptosis: A Possible Pathogenesis of PCOS Follicular Dysplasia.” International Immunopharmacology 125: 111141.
- Xu, J., J. Dun, J. Yang, et al. 2020. “Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways.” Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 26: e923073-1.
- Xu, X., Z. Wang, L. Lv, et al. 2024. “Molecular Regulation of DNA Damage and Repair in Female Infertility: A Systematic Review.” Reproductive Biology and Endocrinology 22, no. 1: 1–13.
- Yousef, M. I., S. A. Omar, M. I. El-Guendi, and L. A. Abdelmegid. 2010. “Potential Protective Effects of Quercetin and Curcumin on Paracetamol-Induced Histological Changes, Oxidative Stress, Impaired Liver & Kidney Functions and Haematotoxicity in Rat.” Food and Chemical Toxicology 48, no. 11: 3246–3261. https://doi.org/10.1016/j.fct.2010.08.034.
- Zaki, M., W. Basha, H. T. El-Bassyouni, S. El-Toukhy, and T. J. G. Hussein. 2018. “Evaluation of DNA Damage Profile in Obese Women and Its Association to Risk of Metabolic Syndrome, Polycystic Ovary Syndrome and Recurrent Preeclampsia.” Genes and Diseases 5, no. 4: 367–373.
- Zeng, X., Y.-J. Xie, Y.-T. Liu, S.-L. Long, and Z.-C. Mo. 2020. “Polycystic Ovarian Syndrome: Correlation Between Hyper&Rogenism, Insulin Resistance and Obesity.” Clinica Chimica Acta 502: 214–221.
- Zhang, Y., M. Hu, F. Meng, et al. 2017. “Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome.” eBioMedicine 18: 157–170.
- Zhou, Y., H. Lan, Z. Dong, et al. 2022. “Rhamnocitrin Attenuates Ovarian Fibrosis in Rats With Letrozole-Induced Experimental Polycystic Ovary Syndrome.” Oxidative Medicine and Cellular Longevity 2022, no. 1: 5558599.
- Zuo, L., Y. Hai, R. Zhang, et al. 2023. “Therapeutic Potential of Icariin in Rats With Letrozole and High-Fat Diet-Induced Polycystic Ovary Syndrome.” European Journal of Pharmacology 953: 175825.
Citing Literature
Article Metrics
Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information
Scite metrics
Explore this article's citation statements on scite.ai
Share QR Code
Generating QR code
QR code copied to clipboard!
Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support.
Export citation
Unable to load citation data. Please try again in a moment.
How to cite
Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619
Download Citation
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download.
This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site.
Citation manager file format
Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (100)
- Polycystic ovary syndrome: Endometrial markers via openalex
- doi:10.1016/j.lfs.2016.03.007 via openalex
- doi:10.1186/s12958-024-01273-z via openalex
- doi:10.1186/s13048-018-0427-7 via openalex
- doi:10.1002/path.1250 via openalex
- doi:10.4172/2155-6156.1000180 via openalex
- doi:10.1016/j.biocel.2010.06.001 via openalex
- doi:10.1016/j.fertnstert.2011.03.021 via openalex
- doi:10.1210/er.2015-1018 via openalex
- doi:10.1016/0221-8747(78)90033-4 via openalex
- doi:10.1016/j.fct.2010.08.034 via openalex
- doi:10.1146/annurev.iy.10.040192.002211 via openalex
- doi:10.1016/j.jpag.2014.01.104 via openalex
- doi:10.1210/en.2012-1693 via openalex
- doi:10.1161/01.res.0000191541.06788.bb via openalex
- doi:10.1093/nar/24.5.992 via openalex
- doi:10.1507/endocrj.42.771 via openalex
- doi:10.1152/ajpendo.00034.2021 via openalex
- doi:10.2174/2210315510999201116205519 via openalex
- doi:10.1097/md.0000000000022241 via openalex
- doi:10.1016/j.jsbmb.2020.105752 via openalex
- doi:10.5455/medarh.2020.74.289-293 via openalex
- doi:10.1007/s10815-022-02429-9 via openalex
- doi:10.1016/j.ejphar.2021.174062 via openalex
- doi:10.1016/j.jsbmb.2022.106179 via openalex
- doi:10.1155/2022/5445291 via openalex
- doi:10.3390/molecules27144476 via openalex
- doi:10.1590/1519-6984.192697 via openalex
- doi:10.7759/cureus.25340 via openalex
- doi:10.1016/j.biopha.2022.112870 via openalex
- doi:10.1186/s13048-018-0400-5 via openalex
- doi:10.1016/j.cca.2019.11.003 via openalex
- doi:10.1007/s00894-020-04356-x via openalex
- doi:10.1016/j.ebiom.2017.03.023 via openalex
- W3185539413 via openalex
- doi:10.1155/2020/7580218 via openalex
- doi:10.1038/s41573-020-00114-z via openalex
- doi:10.1111/jfbc.13729 via openalex
- doi:10.3390/jcm11154509 via openalex
- doi:10.1071/rd19072 via openalex
- doi:10.1007/s00404-020-05951-2 via openalex
- doi:10.3390/molecules27082498 via openalex
- doi:10.18203/2320-1770.ijrcog20181892 via openalex
- doi:10.3390/antiox11101879 via openalex
- doi:10.1155/2018/7421489 via openalex
- doi:10.1016/j.jsbmb.2021.105954 via openalex
- doi:10.1152/ajpendo.00359.2018 via openalex
- doi:10.1111/aji.13644 via openalex
- doi:10.1530/rep-22-0152 via openalex
- doi:10.1007/s10815-020-02014-y via openalex
- doi:10.1155/2022/5558599 via openalex
- doi:10.1002/bdr2.2131 via openalex
- doi:10.1007/s10517-020-04933-3 via openalex
- doi:10.5653/cerm.2020.04231 via openalex
- doi:10.1016/j.ab.2016.10.021 via openalex
- doi:10.1016/j.coph.2022.102345 via openalex
- doi:10.1371/journal.pone.0246265 via openalex
- doi:10.1016/j.nutres.2015.12.008 via openalex
- doi:10.34297/ajbsr.2019.03.000651 via openalex
- doi:10.1016/j.sjbs.2021.06.066 via openalex
- doi:10.1111/andr.13607 via openalex
- doi:10.3390/md21040222 via openalex
- doi:10.3390/molecules29051000 via openalex
- doi:10.1007/s43032-023-01447-x via openalex
- W6685761933 via openalex
- W6799530982 via openalex
- W6848056091 via openalex
- doi:10.1262/jrd.2024-019 via openalex
- doi:10.29261/pakvetj/2023.070 via openalex
- doi:10.20944/preprints202402.0029.v1 via openalex
- doi:10.3389/fendo.2023.1140499 via openalex
- doi:10.3390/ijms242316903 via openalex
- doi:10.31797/vetbio.1451147 via openalex
- doi:10.1016/j.mce.2024.112198 via openalex
- doi:10.21203/rs.3.rs-4788509/v1 via openalex
- doi:10.1007/s43032-025-01820-y via openalex
- doi:10.1016/j.intimp.2023.111141 via openalex
- W6957915596 via openalex
- doi:10.1016/j.steroids.2021.108936 via openalex
- doi:10.1016/j.gendis.2018.03.001 via openalex
- doi:10.21203/rs.3.rs-1384361/v1 via openalex
- doi:10.1007/s13596-022-00652-4 via openalex
- doi:10.1210/endo-102-4-1176 via openalex
- doi:10.5603/gpl.96864 via openalex
- doi:10.1038/s41467-020-20500-w via openalex
- doi:10.12659/msm.923073 via openalex
- doi:10.18502/ijrm.v19i4.9057 via openalex
- doi:10.3109/09513590.2015.1041906 via openalex
- doi:10.22159/ajpcr.2022.v15i12.46060 via openalex
- doi:10.1186/s12958-023-01159-6 via openalex
- doi:10.3390/md19080412 via openalex
- doi:10.1016/j.ctcp.2012.01.005 via openalex
- doi:10.1038/ki.2010.161 via openalex
- doi:10.1002/bdr2.1535 via openalex
- doi:10.1002/fsn3.3646 via openalex
- doi:10.1007/s00404-024-07607-x via openalex
- doi:10.2147/jir.s379725 via openalex
- doi:10.1016/j.ejphar.2022.174746 via openalex
- doi:10.1016/j.ejphar.2023.175825 via openalex
- doi:10.1093/humupd/dmv029 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T03:26:54.866644+00:00
License: CC0
· commercial use OK